Literature DB >> 18261525

Indications for PET/CT in the head and neck.

Vikas Agarwal1, Barton F Branstetter, Jonas T Johnson.   

Abstract

PET/CT has revolutionized the evaluation of patients with head and neck cancer by allowing more accurate staging, more focused treatment modalities, earlier detection of recurrent disease, and identification of incurable disease. In some clinical scenarios, PET/CT is clearly useful, while in others the cost may not be warranted. In this chapter, the authors review the literature on the use of PET/CT in head and neck cancers (in particular squamous cell carcinoma) and provide an evidence-based approach to the use of PET/CT for staging, treatment planning, monitoring of treatment response, and surveillance of treated patients with squamous cell carcinoma. They also briefly address the use of PET/CT for thyroid cancer, lymphoma, and melanoma. At the end of each section, key points are summarized in a box for quick reference.

Entities:  

Mesh:

Year:  2008        PMID: 18261525     DOI: 10.1016/j.otc.2007.10.005

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  15 in total

Review 1.  The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.

Authors:  Joji Kawabe; Shigeaki Higashiyama; Atsushi Yoshida; Kohei Kotani; Susumu Shiomi
Journal:  Jpn J Radiol       Date:  2012-04-05       Impact factor: 2.374

2.  Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.

Authors:  V A Passero; B F Branstetter; Y Shuai; D E Heron; M K Gibson; S Y Lai; S W Kim; J R Grandis; R L Ferris; J T Johnson; A Argiris
Journal:  Ann Oncol       Date:  2010-04-29       Impact factor: 32.976

3.  Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring.

Authors:  Daniel M Beswick; William E Gooding; Jonas T Johnson; Barton F Branstetter
Journal:  Laryngoscope       Date:  2012-06-08       Impact factor: 3.325

4.  FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?

Authors:  Andrei Iagaru; Erik S Mittra; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

5.  No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.

Authors:  R Maquieira; S K Haerle; G F Huber; A Soltermann; S R Haile; S J Stoeckli; Martina A Broglie
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-10       Impact factor: 2.503

6.  Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer.

Authors:  M McDermott; M Hughes; T Rath; J T Johnson; D E Heron; G J Kubicek; S W Kim; R L Ferris; U Duvvuri; J P Ohr; B F Branstetter
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-02       Impact factor: 3.825

7.  Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

Authors:  Jacqueline Dinnes; Lavinia Ferrante di Ruffano; Yemisi Takwoingi; Seau Tak Cheung; Paul Nathan; Rubeta N Matin; Naomi Chuchu; Sue Ann Chan; Alana Durack; Susan E Bayliss; Abha Gulati; Lopa Patel; Clare Davenport; Kathie Godfrey; Manil Subesinghe; Zoe Traill; Jonathan J Deeks; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-07-01

8.  Asymptomatic myocardial metastasis from cancers of upper aero-digestive tract detected on FDG PET/CT: a series of 4 cases.

Authors:  Ameya D Puranik; Nilendu C Purandare; Sheela Sawant; Archi Agrawal; Sneha Shah; Prafful Jatale; Venkatesh Rangarajan
Journal:  Cancer Imaging       Date:  2014-04-28       Impact factor: 3.909

9.  Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.

Authors:  Leechuan Andy Chen; Christopher J Anker; Jason P Hunt; Luke O Buchmann; Kenneth F Grossmann; Kenneth Boucher; Li-Ming Christine Fang; Dennis C Shrieve; Ying J Hitchcock
Journal:  Cancer Med       Date:  2015-01-26       Impact factor: 4.452

Review 10.  PET/MRI in Oncological Imaging: State of the Art.

Authors:  Usman Bashir; Andrew Mallia; James Stirling; John Joemon; Jane MacKewn; Geoff Charles-Edwards; Vicky Goh; Gary J Cook
Journal:  Diagnostics (Basel)       Date:  2015-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.